|
Lincoln Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1188.26 Cr.
|
P/BV
|
1.60
|
Book Value (Rs.)
|
371.63
|
|
52 Week High/Low (Rs.)
|
677/440
|
FV/ML
|
10/1
|
P/E(X)
|
14.43
|
|
Bookclosure
|
12/09/2025
|
EPS (Rs.)
|
41.11
|
Div Yield (%)
|
0.30
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 615.25 | 571.22 | 504.95 | 468.20 | 414.75 |
| Other Operating Revenues | 7.98 | 9.33 | 5.35 | 3.93 | 9.44 |
| Total Operating Revenues | 623.23 | 580.55 | 510.31 | 472.12 | 424.19 |
| | | | | | |
| Other Income | 22.48 | 34.42 | 22.47 | 10.00 | 5.66 |
| Total Revenue | 645.71 | 614.97 | 532.78 | 482.12 | 429.85 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 213.94 | 201.12 | 177.00 | 158.48 | 123.43 |
| Purchase Of Stock-In Trade | 68.54 | 82.91 | 68.64 | 73.67 | 70.31 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 8.84 | -5.70 | -4.24 | -13.57 | 3.99 |
| Employee Benefit Expenses | 112.45 | 102.90 | 93.16 | 70.47 | 60.74 |
| Finance Costs | 1.88 | 1.46 | 2.03 | 1.45 | 1.56 |
| Depreciation And Amortisation Expenses | 12.90 | 10.62 | 9.17 | 8.09 | 7.56 |
| Other Expenses | 117.96 | 99.40 | 86.55 | 87.59 | 78.53 |
| Total Expenses | 536.52 | 492.73 | 432.30 | 386.18 | 346.13 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 109.19 | 122.24 | 100.48 | 95.94 | 83.72 |
| | | | | | |
| Profit/Loss Before Tax | 109.19 | 122.24 | 100.48 | 95.94 | 83.72 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 24.87 | 25.21 | 24.75 | 24.50 | 21.29 |
| Deferred Tax | 1.52 | 3.49 | 1.59 | 0.72 | 0.25 |
| Tax For Earlier Years | 0.45 | 0.24 | 1.24 | 1.37 | -0.07 |
| Total Tax Expenses | 26.84 | 28.94 | 27.58 | 26.58 | 21.47 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 82.35 | 93.30 | 72.90 | 69.36 | 62.25 |
| | | | | | |
| Profit/Loss From Continuing Operations | 82.35 | 93.30 | 72.90 | 69.36 | 62.25 |
| | | | | | |
| Profit/Loss For The Period | 82.35 | 93.30 | 72.90 | 69.36 | 62.25 |
| | | | | | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| Consolidated Profit/Loss After MI And Associates | 82.35 | 93.30 | 72.90 | 69.36 | 62.22 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.11 |
| Diluted EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.11 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 3.61 | 3.00 | 3.00 | 3.00 | 0.00 |
